Downregulation of KEAP1 in melanoma promotes resistance to immune checkpoint blockade

被引：0

作者：

Douglas B. Fox

Richard Y. Ebright

Xin Hong

Hunter C. Russell

Hongshan Guo

Thomas J. LaSalle

Ben S. Wittner

Nicolas Poux

Joanna A. Vuille

Mehmet Toner

Nir Hacohen

Genevieve M. Boland

Debattama R. Sen

Ryan J. Sullivan

Shyamala Maheswaran

Daniel A. Haber

机构：

[1] Massachusetts General Hospital Cancer Center and Harvard Medical School,Center for Engineering in Medicine

[2] Broad Institute of Harvard and MIT,Department of Surgery

[3] Massachusetts General Hospital and Harvard Medical School,Department of Medicine

[4] Shriners Hospitals for Children,Department of Biochemistry, School of Medicine and Key University Laboratory of Metabolism and Health of Guangdong

[5] Massachusetts General Hospital and Harvard Medical School,Liangzhu Laboratory

[6] Massachusetts General Hospital and Harvard Medical School,undefined

[7] Howard Hughes Medical Institute,undefined

[8] Southern University of Science and Technology,undefined

[9] Zhejiang University Medical Center,undefined

来源：

npj Precision Oncology | / 7卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Immune checkpoint blockade (ICB) has demonstrated efficacy in patients with melanoma, but many exhibit poor responses. Using single cell RNA sequencing of melanoma patient-derived circulating tumor cells (CTCs) and functional characterization using mouse melanoma models, we show that the KEAP1/NRF2 pathway modulates sensitivity to ICB, independently of tumorigenesis. The NRF2 negative regulator, KEAP1, shows intrinsic variation in expression, leading to tumor heterogeneity and subclonal resistance.

引用

共 50 条

[31] IMMUNE CHECKPOINT BLOCKADE IS ACTIVE IN MELANOMA BRAIN METASTASES
不详
CANCER DISCOVERY, 2018, 8 (06) : 672 - 672
[32] An angiogenic target of immune exclusion with checkpoint blockade in melanoma
Tabasum, Saba
Thapa, Dinesh
Giobbie-Hurder, Anita
Weirather, Jason L.
Wu, Xinqi
Campisi, Marco
Li, Xiaoyun
Li, Jingjing
Manos, Michael P.
Barbie, David A.
Hodi, F. Stephen
CANCER RESEARCH, 2023, 83 (07)
[33] Hypogonadism in melanoma patients under immune checkpoint blockade
de Vos, L.
Fietz, S.
Fetter, T.
Hillebrand, P.
Allam, P.
Landsberg, J.
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023, 21 : 105 - 105
[34] Dissecting Response and Resistance to Immune Checkpoint Blockade
Liu, David
ONCOLOGIST, 2018, 23 : S4 - S4
[35] Acquired Resistance to Immune Checkpoint Blockade Therapies
Zhao, Xianda
Wangmo, Dechen
Robertson, Matthew
Subramanian, Subbaya
CANCERS, 2020, 12 (05)
[36] Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Re-Induction following Resistance or Toxicity
Koch, Elias A. T.
Petzold, Anne
Wessely, Anja
Dippel, Edgar
Gesierich, Anja
Gutzmer, Ralf
Hassel, Jessica C.
Haferkamp, Sebastian
Kaehler, Katharina C.
Knorr, Harald
Kreuzberg, Nicole
Leiter, Ulrike
Loquai, Carmen
Meier, Friedegund
Meissner, Markus
Mohr, Peter
Pfoehler, Claudia
Rahimi, Farnaz
Schadendorf, Dirk
Schell, Beatrice
Schlaak, Max
Terheyden, Patrick
Thoms, Kai-Martin
Schuler-Thurner, Beatrice
Ugurel, Selma
Ulrich, Jens
Utikal, Jochen
Weichenthal, Michael
Ziller, Fabian
Berking, Carola
Heppt, Markus V.
German Dermatologic Cooperat Oncol Grp
CANCERS, 2022, 14 (03)
[37] EVOLUTION OF HLA HAPLOTYPE LOSS IN MELANOMA PATIENTS AND ITS ASSOCIATION WITH RESISTANCE TO IMMUNE CHECKPOINT BLOCKADE
Zhao, Fang
Schwamborn, Marion
Thier, Beatrice
Crivello, Pietro
Heinold, Andreas
Ahci-Hanci, Mueberra
Meurer, Thuja
Lennerz, Volker
Sucker, Antje
Griewank, Klaus
Horn, Peter A.
Ugurel, Selma
Woelfel, Thomas
Fleischhauer, Katharina
Schadendorf, Dirk
Paschen, Annette
HLA, 2019, 93 (05) : 273 - 273
[38] A machine learning model reveals expansive downregulation of ligand-receptor interactions that enhance lymphocyte infiltration in melanoma with developed resistance to immune checkpoint blockade
Sahni, Sahil
Wang, Binbin
Wu, Di
Dhruba, Saugato Rahman
Nagy, Matthew
Patkar, Sushant
Ferreira, Ingrid
Day, Chi-Ping
Wang, Kun
Ruppin, Eytan
NATURE COMMUNICATIONS, 2024, 15 (01)
[39] NFATC2 target gene signature correlates with immune checkpoint blockade resistance in melanoma
Lawal, Bashir
Wang, Yue
Lotfinejad, Parisa
Sharma, Renu
Yang, Chuang
Annasamudram, Anusha
Wang, Xiao-Song
AMERICAN JOURNAL OF CANCER RESEARCH, 2025, 15 (01):
[40] Immune checkpoint blockade in melanoma by new targeted Dox immunoliposomes
Merino Diaz, M.
Contreras Sandoval, A. M.
Berraondo, K.
Garrido Cid, M. J.
EUROPEAN JOURNAL OF CANCER, 2016, 55 : S18 - S19

← 1 2 3 4 5 →